In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Top Cited Papers
- 18 May 2004
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 31 (1) , 69-75
- https://doi.org/10.1016/j.jcv.2004.03.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Treatment of SARS with human interferonsThe Lancet, 2003
- Immune-Mediated Complications during Interferon Therapy in Hematological PatientsActa Haematologica, 2002
- Flavonoid Baicalin Inhibits HIV-1 Infection at the Level of Viral EntryBiochemical and Biophysical Research Communications, 2000
- Artemisinin drugs: novel antimalarial agentsExpert Opinion on Investigational Drugs, 2000
- Different Relative Activities of Human Cell-Derived Interferon-α Subtypes: IFN-α8 Has Very High Antiviral PotencyJournal of Interferon & Cytokine Research, 1996
- Interferon-Related Bronchiolitis Obliterans Organizing PneumoniaChest, 1994
- Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisAntiviral Research, 1992
- Therapy of genital herpes with topically applied interferonAntimicrobial Agents and Chemotherapy, 1987
- Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersAntimicrobial Agents and Chemotherapy, 1983